Brief: Microbot Medical Completes The Enrollment Of Clinical Sites In Its Pivotal Human Clinical Trial With The Addition Of Memorial Sloan Kettering Cancer Center
18/07/2024 13:34
July 18 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL COMPLETES THE ENROLLMENT OF CLINICAL
SITES IN
ITS PIVOTAL HUMAN CLINICAL TRIAL WITH THE ADDITION OF MEMORIAL
SLOAN KETTERING CANCER CENTER
Source text for Eikon: ID:nGNX6zF8zJ
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsMicrobot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device